Target Gene/Pathway
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z other
No. | KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * | DrugBank | Disease ID * [Number of diseases] |
1 | Alcoholism |
[1] DDC | D00558 | Carbidopa | [8] 2, 4, 6, 13, 17, 90, 164, 201 |
[2] DRD1, DRD2 | D00059 | Levodopa | [7] 2, 4, 6, 17, 90, 164, 201 | ||
2 | Amphetamine addiction |
[1] DDC | D00558 | Carbidopa | [8] 2, 4, 6, 13, 17, 90, 164, 201 |
[1] DRD1 | D00059 | Levodopa | [7] 2, 4, 6, 17, 90, 164, 201 | ||
3 | Calcium signaling pathway |
[2] DRD1, DRD5 | D00059 | Levodopa | [7] 2, 4, 6, 17, 90, 164, 201 |
4 | cAMP signaling pathway |
[3] DRD1, DRD2, DRD5 | D00059 | Levodopa | [7] 2, 4, 6, 17, 90, 164, 201 |
5 | Cocaine addiction |
[1] DDC | D00558 | Carbidopa | [8] 2, 4, 6, 13, 17, 90, 164, 201 |
[2] DRD1, DRD2 | D00059 | Levodopa | [7] 2, 4, 6, 17, 90, 164, 201 | ||
6 | Dopaminergic synapse |
[1] DDC | D00558 | Carbidopa | [8] 2, 4, 6, 13, 17, 90, 164, 201 |
[5] DRD1, DRD2, DRD3, DRD4, DRD5 | D00059 | Levodopa | [7] 2, 4, 6, 17, 90, 164, 201 | ||
7 | GABAergic synapse |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ | D04282 | Gaboxadol | [2] 201, 206 |
8 | Gap junction |
[2] DRD1, DRD2 | D00059 | Levodopa | [7] 2, 4, 6, 17, 90, 164, 201 |
9 | Metabolic pathways |
[1] DDC | D00558 | Carbidopa | [8] 2, 4, 6, 13, 17, 90, 164, 201 |
10 | Morphine addiction |
[1] DRD1 | D00059 | Levodopa | [7] 2, 4, 6, 17, 90, 164, 201 |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ | D04282 | Gaboxadol | [2] 201, 206 | ||
11 | Neuroactive ligand-receptor interaction |
[5] DRD1, DRD2, DRD3, DRD4, DRD5 | D00059 | Levodopa | [7] 2, 4, 6, 17, 90, 164, 201 |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ | D04282 | Gaboxadol | [2] 201, 206 | ||
12 | Nicotine addiction |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ | D04282 | Gaboxadol | [2] 201, 206 |
13 | Parkinson disease |
[2] DRD1, DRD2 | D00059 | Levodopa | [7] 2, 4, 6, 17, 90, 164, 201 |
14 | Phenylalanine metabolism |
[1] DDC | D00558 | Carbidopa | [8] 2, 4, 6, 13, 17, 90, 164, 201 |
15 | Rap1 signaling pathway |
[1] DRD2 | D00059 | Levodopa | [7] 2, 4, 6, 17, 90, 164, 201 |
16 | Retrograde endocannabinoid signaling |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ | D04282 | Gaboxadol | [2] 201, 206 |
17 | Serotonergic synapse |
[1] DDC | D00558 | Carbidopa | [8] 2, 4, 6, 13, 17, 90, 164, 201 |
[3] GABRB1, GABRB2, GABRB3 | D04282 | Gaboxadol | [2] 201, 206 | ||
18 | Taste transduction |
[6] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 | D04282 | Gaboxadol | [2] 201, 206 |
19 | Tryptophan metabolism |
[1] DDC | D00558 | Carbidopa | [8] 2, 4, 6, 13, 17, 90, 164, 201 |
20 | Tyrosine metabolism |
[1] DDC | D00558 | Carbidopa | [8] 2, 4, 6, 13, 17, 90, 164, 201 |